Correlation of macrophage migration inhibitory factor gene polymorphism with the risk of early stage cervical cancer and lymphatic metastasis

  • Authors:
    • Suhui Wu
    • Junfang Lian
    • Huijuan Tao
    • Haixia Shang
    • Li Zhang
  • View Affiliations

  • Published online on: September 2, 2011     https://doi.org/10.3892/ol.2011.409
  • Pages: 1261-1267
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Associations of functional single nucleotide polymorphisms in MIF-173G/C with early stage cervical cancer were investigated in a hospital-based case-control study on 250 patients with cervical cancer prior to surgery (including 49 cases with and 201 cases without lymphatic metastasis) and 147 healthy controls. The polymorphism was assessed using restriction fragment length polymorphism polymerase chain reaction, and the MIF serum concentration was examined using the enzyme-linked immunosorbent assay to analyze the correlation between the polymorphism and the MIF serum concentration. Carriers of the variant C allele in MIF-173 were at a significantly higher risk of cervical cancer compared to carriers of the wild-type allele (aOR=1.508; 95% CI 1.128-2.016, p=0.05). The GC and CC genotypes may be the causative factors for cervical cancer (aOR=1.851; 95% CI 1.132‑3.027, p=0.013). Individuals with the GC+CC genotype and C allele at the MIF-173G/C site were at a significantly higher risk of cervical cancer and lymphatic metastasis. The risk of lymphatic metastasis in early stage cervical cancer was increased more than 1.6 times in patients with the CC and GC genotypes compared with those with the GG genotype. The genotype distribution and allele frequency of MIF-173G/C were statistically significant in the well-, moderately and poorly differentiated groups (P<0.05). Compared to the GG genotype and G allele, patients with GC and CC genotypes and C allele exhibited a lower degree of differentiation and a higher degree of malignancy. A significant difference was observed in MIF serum concentrations among the various subgroups (P<0.05). The early cervical cancer, lymphatic metastasis and poorly differentiated groups exhibited higher MIF levels in serum. Moreover, patients with the CC genotype exhibited higher MIF serum concentration, which could increase the risk of early stage cervical cancer and lymphatic metastasis. The results presented in this study provide the first evidence that the genetic polymorphism MIF-173 is associated with cervical cancer in humans. Detection of MIF serum concentration and genotyping may be used as biomarkers for early diagnosis and therapy for cervical cancer.
View References

Related Articles

Journal Cover

November-December 2011
Volume 2 Issue 6

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Wu S, Lian J, Tao H, Shang H and Zhang L: Correlation of macrophage migration inhibitory factor gene polymorphism with the risk of early stage cervical cancer and lymphatic metastasis. Oncol Lett 2: 1261-1267, 2011
APA
Wu, S., Lian, J., Tao, H., Shang, H., & Zhang, L. (2011). Correlation of macrophage migration inhibitory factor gene polymorphism with the risk of early stage cervical cancer and lymphatic metastasis. Oncology Letters, 2, 1261-1267. https://doi.org/10.3892/ol.2011.409
MLA
Wu, S., Lian, J., Tao, H., Shang, H., Zhang, L."Correlation of macrophage migration inhibitory factor gene polymorphism with the risk of early stage cervical cancer and lymphatic metastasis". Oncology Letters 2.6 (2011): 1261-1267.
Chicago
Wu, S., Lian, J., Tao, H., Shang, H., Zhang, L."Correlation of macrophage migration inhibitory factor gene polymorphism with the risk of early stage cervical cancer and lymphatic metastasis". Oncology Letters 2, no. 6 (2011): 1261-1267. https://doi.org/10.3892/ol.2011.409